Veralox Therapeutics

About:

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

Website: https://www.veralox.com

Top Investors: Sanofi, Alumni Ventures, Alexandria Venture Investments, TEDCO, Hatteras Venture Partners

Description:

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.